Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients

BACKGROUND: Hepatitis C virus (HCV) infects more than 71 million people worldwide and chronic HCV infection increases the risk of liver cirrhosis and failure. Haemodialysis (HD) is one of the renal replacement therapies with risk of HCV transmission. Anti-HCV antibodies are the serological screening...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Nephrol
Prif Awduron: Wong, Xue Zheng, Gan, Chye Chung, Mohamed, Rosmawati, Yahya, Rosnawati, Ganapathy, Shubash, Tan, Soek Siam, Lim, Soo Kun
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2020
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7666439/
https://ncbi.nlm.nih.gov/pubmed/33187498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-02154-4
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg